Skip to main content
Premium Trial:

Request an Annual Quote

Clay Marsh Talks Personalized Medicine

In a recent MedCity News interview, the Ohio State University Medical Center's Clay Marsh described his institution's "push into personalized medicine," though he said that the term connotes different meanings. "To some, personalized medicine means genomic medicine. Others might see it as patient-centered medicine," he said. Whichever the case, at present, personalized medicine "focuses on disease-based care," Marsh told MedCity News. "But the game-changer will be to help people stay healthy." Of the school's decision to join the P4 Medicine Institute, Marsh said that OSU intends to bring technologies developed at Seattle's Institute for Systems Biology "to the patient-care environment." For personalized medicine to become standard practice, "it has to consist of systems of care" and also "be scalable and portable," Marsh said, adding that once it's simply referred to as "medicine," researchers will have achieved substantial success in this arena.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.